{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-106238","form_type":"8-K","ticker":"ESLA","cik":"0001844417","company_name":"Estrella Immunopharma, Inc.","filed_at":"2024-12-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.998508+00:00","generated_at":"2026-05-29T06:44:19.574058+00:00","sec_items":["1.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Estrella Immunopharma extends equity line with White Lion to Dec 2025, adds rapid share purchase mechanism","bullets":["Amendment extends existing up-to-$50M stock purchase agreement from Dec 30, 2024 to Dec 30, 2025.","New 'Rapid Purchase' mechanism allows expedited share sales at lowest traded price on notice date.","Rapid purchase limit is the lesser of 20% of average daily trading volume or investment limit divided by highest close over five days.","Standard purchase discount remains 97% (up to $25M) then 98%; rapid purchases use lowest traded price (0% discount).","Company delivers Rapid Purchase Notice by 11:00 a.m. NY time with concurrent DWAC transfer; payment due next business day by 5 p.m."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-106238","json":"https://secwatch.observer/filing/0001213900-24-106238.json","markdown":"https://secwatch.observer/filing/0001213900-24-106238.md","text":"https://secwatch.observer/filing/0001213900-24-106238.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1844417/000121390024106238/0001213900-24-106238-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1844417/000121390024106238/ea0223902-8k_estrella.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T06:44:19.574058+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}